We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.49B
1-Year Est. Return
19.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+19.44%
3 Year Est. Return
+59.91%
5 Year Est. Return
+54.26%
10 Year Est. Return
+227.54%
AUM
$3.09B
AUM Growth
+$600M
(+24%)
Cap. Flow
-$2.6B
Cap. Flow
% of AUM
-84.13%
Top 10 Holdings %
Top 10 Hldgs %
58.75%
Holding
380
New
–
Increased
–
Reduced
–
Closed
54
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$226M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$196M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$159M |
| 4 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$157M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 70.74% |
| 2 | Financials | 8.61% |
| 3 | Consumer Discretionary | 4.59% |
| 4 | Technology | 4.59% |
| 5 | Communication Services | 4.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
AbbVie
ABBV
$460B
| – | – |
0
| – | – |
|
77
Morgan Stanley
MS
$341B
| – | – |
0
| – | – |
|
78
Merck
MRK
$376B
| – | – |
0
| – | – |
|
79
Nike
NKE
$57.5B
| – | – |
0
| – | – |
|
80
Goldman Sachs
GS
$302B
| – | – |
0
| – | – |
|
81
Thermo Fisher Scientific
TMO
$229B
| – | – |
0
| – | – |
|
82
Intel
INTC
$485B
| – | – |
0
| – | – |
|
83
Cisco
CSCO
$428B
| – | – |
0
| – | – |
|
84
Broadcom
AVGO
$1.7T
| – | – |
0
| – | – |
|
85
McDonald's
MCD
$184B
| – | – |
0
| – | – |
|
86
Eli Lilly
LLY
$1.03T
| – | – |
0
| – | – |
|
87
Danaher
DHR
$148B
| – | – |
0
| – | – |
|
|
SCHW
88
Charles Schwab
SCHW
$191B
| – | – |
0
| – | – |
|
89
S&P Global
SPGI
$133B
| – | – |
0
| – | – |
|
90
Amgen
AMGN
$240B
| – | – |
0
| – | – |
|
91
Bristol-Myers Squibb
BMY
$139B
| – | – |
0
| – | – |
|
92
Accenture
ACN
$118B
| – | – |
0
| – | – |
|
93
Lowe's Companies
LOW
$113B
| – | – |
0
| – | – |
|
94
Texas Instruments
TXN
$232B
| – | – |
0
| – | – |
|
95
Starbucks
SBUX
$121B
| – | – |
0
| – | – |
|
96
Intuit
INTU
$94.2B
| – | – |
0
| – | – |
|
97
ConocoPhillips
COP
$163B
| – | – |
0
| – | – |
|
98
Target
TGT
$74.5B
| – | – |
0
| – | – |
|
99
Oracle
ORCL
$444B
| – | – |
0
| – | – |
|
100
Intuitive Surgical
ISRG
$131B
| – | – |
0
| – | – |
|
Similar funds
WSFS
5NCM
DACG
MAM
U
ACM
EFM
WestEnd Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, WestEnd Advisors held 380 positions worth $3.09B, up 24% from $2.49B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
WestEnd Advisors withdrew a net $2.6B in Q2 2021, closing 54 positions. Its most notable exit was Vanguard FTSE All-World ex-US ETF, an estimated $226M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, up from 66% a quarter earlier, followed by Financials and Consumer Discretionary.
- WestEnd Advisors fully exited Vanguard FTSE All-World ex-US ETF in Q2 2021, selling an estimated $226M.
- WestEnd Advisors's ten largest holdings make up 59% of its $3.09B portfolio in Q2 2021.
- WestEnd Advisors opened 0 new positions and closed 54 in Q2 2021.
- WestEnd Advisors's portfolio value rose 24% quarter-over-quarter to $3.09B.
Based on WestEnd Advisors's 13F filing for Q2 2021, filed 15 Jul 2021.